摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,4aS,12aS)-2-acetyl-4-amino-3,10,11,12a-tetrahydroxy-6,9-dimethyl-4a,5-dihydro-4H-tetracene-1,12-dione

中文名称
——
中文别名
——
英文名称
(4R,4aS,12aS)-2-acetyl-4-amino-3,10,11,12a-tetrahydroxy-6,9-dimethyl-4a,5-dihydro-4H-tetracene-1,12-dione
英文别名
——
(4R,4aS,12aS)-2-acetyl-4-amino-3,10,11,12a-tetrahydroxy-6,9-dimethyl-4a,5-dihydro-4H-tetracene-1,12-dione化学式
CAS
——
化学式
C22H21NO7
mdl
——
分子量
411.4
InChiKey
IRCLZBUBOWPFCH-ONJZCGHCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    30
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    158
  • 氢给体数:
    5
  • 氢受体数:
    8

文献信息

  • [EN] SUBSTITUTED TETRACYCLINE COMPOUNDS<br/>[FR] COMPOSÉS À BASE DE TÉTRACYCLINES SUBSTITUÉES
    申请人:PARATEK PHARM INNC
    公开号:WO2009128913A1
    公开(公告)日:2009-10-22
    The present invention pertains, at least in part, to methods of treating a microorganism-associated infection in a subject comprising administering to said subject an effective amount of a tetracycline compound.
    本发明至少部分涉及治疗宿主微生物相关感染的方法,包括向宿主施用有效量的四环素化合物。
  • Substituted Tetracycline Compounds
    申请人:Kim Oak K.
    公开号:US20100305072A1
    公开(公告)日:2010-12-02
    The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.
    本发明至少部分涉及新型替代四环素化合物。这些四环素化合物可用于治疗许多对四环素化合物敏感的疾病状态,如细菌感染和肿瘤。
  • [EN] CARBONATE PRODRUGS AND METHODS OF USING THE SAME<br/>[FR] PROMÉDICAMENTS CARBONATÉS ET LEURS MÉTHODES D'UTILISATION
    申请人:NEUROGESX INC
    公开号:WO2009143297A1
    公开(公告)日:2009-11-26
    The present invention provides carbonate prodrugs which comprise a carbonic phosphoric anhydride prodrug moiety attached to the hydroxyl or carboxyl group of a parent drug moiety. The prodrugs may provide improved physicochemical properties over the parent drug. Also provided are methods of treating a disease or condition that is responsive to the parent drug using the carbonate prodrugs, as well as kits and unit dosages.
    本发明提供了碳酸盐前药,其包括连接到母药基团的羟基或羧基上的碳酸磷酸酐前药基团。这些前药可能比母药具有改进的物理化学性质。还提供了使用碳酸盐前药治疗对母药具有响应的疾病或症状的方法,以及配套工具和单剂量。
  • 9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUNDS
    申请人:Zhang Hui
    公开号:US20140179638A1
    公开(公告)日:2014-06-26
    The present invention relates to 9-aminomethyl substituted tetracycline compounds represented by formula (I), or pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, as well as a method for preparing these compounds and a pharmaceutical composition comprising the same. The present invention relates also to a use of these compounds in the preparation of a medicament for the treatment and/or prophylaxis of tetracycline drug-sensitive disease. wherein, R 2a , R 2b , R 3 , R 4a , R 4b , R 5 , R 6a , R 6b , R 7 , R 8 , R 9a , R 9b , R 10 , R 11 , R 12 , R 13a and R 13b are each independently as defined in the description.
    本发明涉及由式(I)表示的9-甲基取代四环素化合物,或其药学上可接受的盐、前药、溶剂化合物或异构体,以及制备这些化合物的方法和包含其的药物组合物。本发明还涉及这些化合物在制备用于治疗和/或预防四环素药物敏感疾病的药物中的用途。其中,R2a、R2b、R3、R4a、R4b、R5、R6a、R6b、R7、R8、R9a、R9b、R10、R11、R12、R13a和R13b各自独立地如描述中所定义。
  • 10-substituted tetracyclines and methods of use thereof
    申请人:Abato Paul
    公开号:US20070093455A1
    公开(公告)日:2007-04-26
    10-Substituted tetracycline compounds are described.
    描述了10-取代四环素化合物。
查看更多